1. Cybulski, Cezary, Zamani, Neda, Kluźniak, Wojciech, Lubiński, Jan, Akbari, Mohammad R. 2023. Variants in ATRIP are associated with breast cancer susceptibility in the Polish population and UK Biobank. In American journal of human genetics, 110, 648-662. doi:10.1016/j.ajhg.2023.03.002. https://pubmed.ncbi.nlm.nih.gov/36977412/
2. Duthoo, Evi, Beyls, Elien, Backers, Lynn, Claes, Kathleen B M, Tavernier, Simon J. 2025. Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients. In The Journal of experimental medicine, 222, . doi:10.1084/jem.20241432. https://pubmed.ncbi.nlm.nih.gov/40029331/
3. Lin, Yunfeng, Li, Jia, Zhao, Haichao, McGhee, Kelly, Yan, Shan. 2023. APE1 recruits ATRIP to ssDNA in an RPA-dependent and -independent manner to promote the ATR DNA damage response. In eLife, 12, . doi:10.7554/eLife.82324. https://pubmed.ncbi.nlm.nih.gov/37216274/
4. Zhang, Hui, Head, PamelaSara E, Daddacha, Waaqo, Gius, David, Yu, David S. 2016. ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA. In Cell reports, 14, 1435-1447. doi:10.1016/j.celrep.2016.01.018. https://pubmed.ncbi.nlm.nih.gov/26854234/
5. Ogi, Tomoo, Walker, Sarah, Stiff, Tom, O'Driscoll, Mark, Jeggo, Penny A. 2012. Identification of the first ATRIP-deficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel Syndrome. In PLoS genetics, 8, e1002945. doi:10.1371/journal.pgen.1002945. https://pubmed.ncbi.nlm.nih.gov/23144622/
智鼠故事 
